Byotrol Share Price, News & Analysis (LON:BYOT) GBX 0.57 -0.03 (-4.17%) (As of 03:18 PM ET) Add Compare Share Share Today's Range 0.58▼ 0.6550-Day Range 0.44▼ 1.5552-Week Range 0.42▼ 2.70Volume402,998 shsAverage Volume431,366 shsMarket Capitalization£2.61 millionP/E RatioN/ADividend Yield5.49%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades About Byotrol Stock (LON:BYOT)Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. The company operates through Professional and Consumer segments. Its product portfolio includes Actizone, a antimicrobial technology which improves cleaning performance and long-lasting protection against bacteria; and Byotrol, a long-lasting antimicrobial protection for various applications including bathroom cleaners to multi-surface wipes. The company also offers HLD4, a broad-spectrum disinfectant designed for high soil environments of the animal health sector; and Invirtu for skin care. It serves human and animal health, facilities management, food and beverages, household, and skin and pet care markets. The company was incorporated in 2005 and is headquartered in Chester, the United Kingdom.Read More BYOT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BYOT Stock News HeadlinesDecember 7, 2023 | lse.co.ukByotrol shares jump as optimistic despite half-year loss wideningDecember 1, 2023 | americanbankingnews.comByotrol (LON:BYOT) Share Price Passes Below 200-Day Moving Average of $1.52December 8, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 23, 2023 | lse.co.ukMirriad Advertising confirms Nic Hellyer has joined as new CFONovember 14, 2023 | lse.co.ukTRADING UPDATES: Byotrol interim sales flat; Argo loss narrowsNovember 5, 2023 | lse.co.ukUbsetf Usfm Regulatory NewsSeptember 27, 2023 | lse.co.ukByotrol CEO Pinto steps down; ex-CEO appointed as interimSeptember 27, 2023 | marketwatch.comByotrol CEO Vivan Pinto Steps Down; Former Chief Executive Appointed Interim ReplacementDecember 8, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 7, 2023 | marketwatch.comByotrol Sees Lower-Than-Expected Revenue on Slow Europe GrowthSeptember 5, 2023 | finance.yahoo.comNorth America Hand Sanitizer Market to Worth USD 1.86 Billion by 2030 | With a Striking 4.9% CAGRAugust 26, 2023 | uk.finance.yahoo.comBYOT.L - Byotrol plcAugust 1, 2023 | finance.yahoo.comByotrol Full Year 2023 Earnings: UK£0.26 loss per share (vs UK£0.003 loss in FY 2022)July 31, 2023 | lse.co.ukTRADING UPDATES: Byotrol loss widens, Surface Transforms sales growJuly 6, 2023 | marketwatch.comByotrol Granted UK Patent for Seaweed-Derived AntiviralJuly 6, 2023 | lse.co.ukByotrol shares up as wins patent for novel anti-viral seaweed extractMay 26, 2023 | msn.comSMALL CAP MOVERS: Irish oil and gas industry shares slumpMay 26, 2023 | msn.comSMALL CAP MOVERS: Irish oil and gas firms knocked over by government minister shutting down exploration bidMay 24, 2023 | marketwatch.comByotrol Shares Rise on Sanitizer Virucidal Claims ApprovalMay 8, 2023 | marketwatch.comNorth America Hand Sanitizer Market: Size and Share 2023 | Growth Analysis with 7.1% CAGR Forecast by 2026April 28, 2023 | marketwatch.comByotrol Sees FY 2023 Meeting Market Views; Names Trevor Francis as ChairmanApril 27, 2023 | lse.co.ukTRADING UPDATES: Yourgene Health sees revenue above market forecastsApril 6, 2023 | marketwatch.comHand Sanitizer Market 2023 Size and Forecast to 2031March 21, 2023 | marketwatch.com2023-2029 Enzyme Cleaner for Medical Device Market Size and Consumption Analysis by Region | Latest Report by Absolute ReportsNovember 22, 2022 | marketwatch.comByotrol Chairman John Langlands to Retire Jan. 31November 8, 2022 | marketwatch.comPet Deodorizer Market Size, Share & Trends Analysis Report By Product, By Application, By Region, And Segment Forecasts, 2022 - 2028August 31, 2022 | lse.co.ukGerman inflation hits highest level in nearly 50 yearsSee More Headlines Receive BYOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Byotrol and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/19/2019Today12/08/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Household & Personal Products Sub-IndustryN/A SectorConsumer Defensive Current SymbolLON:BYOT CUSIPN/A CIKN/A Webwww.byotrol.co.uk Phone+44-1925-742000FaxN/AEmployees36Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio3.24 P/E GrowthN/ANet Income£-1,690,000.00 Net Margins-36.85% Pretax MarginN/A Return on Equity-26.60% Return on Assets-12.10% Debt Debt-to-Equity Ratio17.38 Current Ratio3.27 Quick Ratio3.36 Sales & Book Value Annual Sales£4.59 million Price / Sales0.64 Cash FlowGBX 8.48 per share Price / Cash Flow0.08 Book ValueGBX 1 per share Price / Book0.65Miscellaneous Outstanding Shares453,890,000Free FloatN/AMarket Cap£2.95 million OptionableNot Optionable Beta-0.16 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. David Thomas Traynor (Age 57)Interim CEO & Executive Director Comp: $189kMr. Christopher John Sedwell (Age 46)CFO & Director Comp: $159kDr. Chris PlummerHead of TechnologyMs. Denise Yvonne Keenan ACAChief Commercial Officer & Company SecretaryKey CompetitorsCellular GoodsLON:CBXBrand Architekts GroupLON:BAREverest GlobalLON:EVSTDistilLON:DISReal Good FoodLON:RGDView All CompetitorsInsidersVivan PintoBought 400,000 shares on 9/8/2023Total: £800,000.00 ($2.00/share)Vivan PintoBought 500,000 shares on 5/22/2023Total: £1 M ($2.00/share)Vivan PintoBought 300,000 shares on 4/27/2023Total: £600,000.00 ($2.00/share)Vivan PintoBought 300,000 shares on 1/31/2023Total: £600,000.00 ($2.00/share)Vivan PintoBought 1,100,000 shares on 12/21/2022Total: £2.20 M ($2.00/share)View All Insider Transactions BYOT Stock Analysis - Frequently Asked Questions How have BYOT shares performed in 2023? Byotrol's stock was trading at GBX 2.50 at the start of the year. Since then, BYOT shares have decreased by 77.0% and is now trading at GBX 0.58. View the best growth stocks for 2023 here. How were Byotrol's earnings last quarter? Byotrol plc (LON:BYOT) posted its earnings results on Thursday, December, 19th. The company reported ($0.15) EPS for the quarter. Byotrol had a negative trailing twelve-month return on equity of 26.60% and a negative net margin of 36.85%. What other stocks do shareholders of Byotrol own? Based on aggregate information from My MarketBeat watchlists, some companies that other Byotrol investors own include Communisis (CMS), Cineworld Group (CINE), Ardent Leisure Group Limited Stapled Securities (AAD), General Electric (GE), International Consolidated Airlines Group (IAG), Lloyds Banking Group (LLOY), Myer (MYR), NetPlay TV (NPT), Qantas Airways (QAN) and Rolls-Royce Holdings plc (RR). How do I buy shares of Byotrol? Shares of BYOT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:BYOT) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Byotrol plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.